Nice to get a re-tweet and reply from @CTADConference yesterday.
My post that was re-tweeted:
"ASN, AHA & CTAD presentations upcoming for #Resverlogix to reveal all the details of #apabetalone effects on renal, cardiovascular and cognition outcomes in #BETonMACE. #AHA19 #CTAD19 #KidneyWeek @AHAMeetings @CTADconference @ASNKidney. Abstracts here: https://tinyurl.com/yy9o8yes"
@CTADConference reply:
"Excited to have @Resverlogix_RVX present at #CTAD19 @CTADconference"